Navigation Links
AstraZeneca Among Working Mother Magazine's 2009 'Best Companies'
Date:9/22/2009

WILMINGTON, Del., Sept. 22 /PRNewswire-FirstCall/ --- AstraZeneca (NYSE: AZN) has been recognized as one of the 2009 Working Mother 100 Best Companies for the eighth consecutive year. This award acknowledges the company's commitment to family-friendly policies that support employee retention, employee engagement, and career advancement.

This year, the company was recognized specifically for its best practices in parental leave and training and development. AstraZeneca provides each eligible employee with up to 52 weeks of combined paid and unpaid leave, 26 weeks of which is job guaranteed, to care for their newborn child, adopted or foster child. The company also offers paid adoption leave.

In training and development, the company expanded the IDEA program, which provides short term development opportunities to enable individuals to develop new skills and explore alternate careers through work experience in different areas within the company while staying in their current position. The program matches employees who want to learn and have skills to share with host project managers.

"AstraZeneca strives to create an inclusive culture of innovation and opportunity to help employees manage the growing demands of work and personal life," says Marta Brito Perez, Vice President, Human Resources, North America & Global Marketing. "This recognition from Working Mother magazine underscores our commitment to the health and welfare of our employees."

Additional programs the company offers include:

  • Childcare and eldercare resources, services and discounts
  • Flexible work arrangements
  • Work/life seminars
  • Employee Assistance Program providing confidential, personal support, resources and referrals to help solve a wide range of personal and work-related challenges
  • Assistance in selecting, financing and applying to college through seminars, individual sessions with a specialist and access to online resources
  • Programs to encourage healthy lifestyles

Workplace support is also provided to employees through diverse employee network groups, which bring together employees with similar interests and experiences and provide opportunities for networking, professional development and community outreach. For example, the company offers employee network groups for women, working parents, elder caregivers, mature workers and employees who care for people with disabilities.

This year, Working Mother magazine selected companies based on an extensive application with more than 500 questions on topics such as workforce, compensation, child care, flexibility programs, leave policies and more, with particular weight was given to benefits, flexibility and parental leave. Profiles of the 100 Best Companies, as well as national comparisons, are in the October issue of Working Mother and at workingmother.com.

About Working Mother Media

Celebrating 30 years, Working Mother magazine reaches 2 million readers and is the only national magazine for career-committed mothers while workingmother.com brings to the Web a broad range of insight and solutions served to working mothers every day. Working Mother's 24-year signature research initiative, Working Mother 100 Best Companies, is the most important benchmark for work-life practices in corporate America. With offices in New York and Washington, D.C., Working Mother Media, a division of Bonnier Corp., includes the National Association for Female Executives, Diversity Best Practices, the WorkLife Congress and the Multicultural Women's Conference and Town Halls. Working Mother Media's mission is to champion cultural change.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM)Prescription Savings programs, please visit: www.astrazeneca-us.com.


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: